203 related articles for article (PubMed ID: 26369589)
1. Twelve- and 52-week safety of albuterol multidose dry powder inhaler in patients with persistent asthma.
Raphael G; Taveras H; Iverson H; O'Brien C; Miller D
J Asthma; 2016; 53(2):187-93. PubMed ID: 26369589
[TBL] [Abstract][Full Text] [Related]
2. Albuterol multidose dry powder inhaler efficacy and safety versus placebo in children with asthma.
LaForce C; Taveras H; Iverson H; Shore P
Allergy Asthma Proc; 2017 Jan; 38(1):28-37. PubMed ID: 28052799
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics, Pharmacodynamics, Efficacy, and Safety of Albuterol (Salbuterol) Multi-dose Dry-Powder Inhaler and ProAir(®) Hydrofluoroalkane for the Treatment of Persistent Asthma: Results of Two Randomized Double-Blind Studies.
Kerwin EM; Taveras H; Iverson H; Wayne D; Shah T; Lepore MS; Miller DS
Clin Drug Investig; 2016 Jan; 36(1):55-65. PubMed ID: 26541599
[TBL] [Abstract][Full Text] [Related]
4. Randomized, dose-ranging study of a fluticasone propionate multidose dry powder inhaler in adolescents and adults with uncontrolled asthma not previously treated with inhaled corticosteroids.
Kerwin EM; Gillespie M; Song S; Steinfeld J
J Asthma; 2017 Jan; 54(1):89-98. PubMed ID: 27285965
[TBL] [Abstract][Full Text] [Related]
5. Novel albuterol multidose dry powder inhaler in patients with exercise-induced bronchoconstriction: A single-dose, double-blind, randomized, 2-way crossover study.
Ostrom NK; Taveras H; Iverson H; Pearlman DS
Respir Med; 2015 Nov; 109(11):1410-5. PubMed ID: 26475054
[TBL] [Abstract][Full Text] [Related]
6. A 6-month safety and efficacy study of fluticasone propionate and fluticasone propionate/salmeterol multidose dry powder inhalers in persistent asthma.
Mansfield L; Yiu G; Sakov A; Liu S; Caracta C
Allergy Asthma Proc; 2017 Jul; 38(4):264-276. PubMed ID: 28540844
[TBL] [Abstract][Full Text] [Related]
7. Albuterol multidose dry powder inhaler and albuterol hydrofluoroalkane versus placebo in children with persistent asthma.
Qaqundah PY; Taveras H; Iverson H; Shore P
Allergy Asthma Proc; 2016 Sep; 37(5):350-8. PubMed ID: 27657520
[TBL] [Abstract][Full Text] [Related]
8. Fluticasone propionate and fluticasone propionate/salmeterol multidose dry powder inhalers compared with placebo for persistent asthma.
Sher LD; Yiu G; Sakov A; Liu S; Caracta CF
Allergy Asthma Proc; 2017 Sep; 38(5):343-353. PubMed ID: 28639542
[TBL] [Abstract][Full Text] [Related]
9. Safety, efficacy, and dose response of fluticasone propionate delivered via the novel MDPI in patients with severe asthma: A randomized, controlled, dose-ranging study.
Bernstein DI; Gillespie M; Song S; Steinfeld J
J Asthma; 2017 Aug; 54(6):559-569. PubMed ID: 27937064
[TBL] [Abstract][Full Text] [Related]
10. Efficacy, tolerability, and effect on asthma-related quality of life of formoterol bid via multidose dry powder inhaler and albuterol QID via metered dose inhaler in patients with persistent asthma: a multicenter, randomized, double-blind, double-dummy, placebo-controlled, parallel-group study.
Busse W; Levine B; Andriano K; Lavecchia C; Yegen U
Clin Ther; 2004 Oct; 26(10):1587-98. PubMed ID: 15598475
[TBL] [Abstract][Full Text] [Related]
11. Dose-ranging study of salmeterol using a novel fluticasone propionate/salmeterol multidose dry powder inhaler in patients with persistent asthma.
Miller DS; Yiu G; Hellriegel ET; Steinfeld J
Allergy Asthma Proc; 2016 Jul; 37(4):291-301. PubMed ID: 27216137
[TBL] [Abstract][Full Text] [Related]
12. Randomized, double-blind trial evaluating the efficacy and safety of fluticasone propionate and fluticasone propionate/salmeterol delivered via multidose dry powder inhalers in patients with persistent asthma aged 12 years and older.
Raphael G; Yiu G; Sakov A; Liu S; Caracta C
J Asthma; 2018 Jun; 55(6):640-650. PubMed ID: 28763243
[TBL] [Abstract][Full Text] [Related]
13. The pharmacokinetics, safety, and tolerability of single, high-strength doses of fluticasone propionate and fluticasone propionate/salmeterol delivered via a novel multidose dry powder inhaler in adolescents and adults with persistent asthma.
Nugent C; Yiu G; Song S; Caracta C
J Asthma; 2018 Aug; 55(8):898-906. PubMed ID: 28933971
[TBL] [Abstract][Full Text] [Related]
14. Prospective, open-label evaluation of a new albuterol multidose dry powder inhaler with integrated dose counter.
Given J; Taveras H; Iverson H
Allergy Asthma Proc; 2016 May; 37(3):199-206. PubMed ID: 26831652
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics, pharmacodynamics, and clinical efficacy of albuterol RespiClick(™) dry-powder inhaler in the treatment of asthma.
Welch MJ
Expert Opin Drug Metab Toxicol; 2016 Sep; 12(9):1109-19. PubMed ID: 27424535
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of fluticasone propionate multidose, inhalation-driven, novel, dry powder inhaler versus a prevailing dry powder inhaler and a metered-dose inhaler.
Gillespie M; Song S; Steinfeld J
Allergy Asthma Proc; 2015; 36(5):365-71. PubMed ID: 26314817
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and tolerability of fluticasone propionate/salmeterol administered twice daily via hydrofluoroalkane 134a metered-dose inhaler in adolescent and adult patients with persistent asthma: a randomized, double-blind, placebo-controlled, 12-week study.
Nathan RA; Rooklin A; Schoaf L; Scott C; Ellsworth A; House K; Dorinsky P
Clin Ther; 2006 Jan; 28(1):73-85. PubMed ID: 16490581
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics and pharmacodynamics of albuterol multidose dry powder inhaler and albuterol hydrofluoroalkane in children with asthma.
Ratnayake A; Taveras H; Iverson H; Shore P
Allergy Asthma Proc; 2016 Sep; 37(5):370-5. PubMed ID: 27523719
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of formoterol delivered via a new multidose dry powder inhaler (Certihaler) in adolescents and adults with persistent asthma.
LaForce C; Prenner BM; Andriano K; Lavecchia C; Yegen U
J Asthma; 2005 Mar; 42(2):101-6. PubMed ID: 15871441
[TBL] [Abstract][Full Text] [Related]
20. The CONCEPT trial: a 1-year, multicenter, randomized,double-blind, double-dummy comparison of a stable dosing regimen of salmeterol/fluticasone propionate with an adjustable maintenance dosing regimen of formoterol/budesonide in adults with persistent asthma.
FitzGerald JM; Boulet LP; Follows RM
Clin Ther; 2005 Apr; 27(4):393-406. PubMed ID: 15922813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
